×

Advising Valeant's hostile bid

10:39 AM ET Mon, 27 Oct 2014

CNBC's David Faber speaks to Robert Kindler, Morgan Stanley head of global M&A, about Valeant's takeover strategy of Allergan and the complexity of a hostile bid.